American College of Occupational and Environmental Medicine (ACOEM): A Professional Association in Service to Industry

International Journal of Occupational and Environmental Health

Volumn 13, Issue 4, 2007, Pages 404-426

  LaDou, Joseph ^a   Teitelbaum, Daniel T ^b   Egilman, David S ^b   Frank, Arthur L ^b   Kramer, Sharon N ^b   Huff, James ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

American College of Occupational and Environmental Medicine; Conflicts of interest; Industry influence; Policy; Public health

Indexed keywords

ALCOHOL; ASBESTOS; BERYLLIUM; CHEMICAL AGENT;

AIR POLLUTION; CLINICAL PRACTICE; CONFLICT OF INTEREST; ENVIRONMENTAL PROTECTION; ERGONOMICS; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SERVICE; HISTORY OF MEDICINE; HUMAN; LABORATORY TEST; MEDICAL DOCUMENTATION; MEDICAL RESEARCH; MEDICOLEGAL ASPECT; OCCUPATIONAL CANCER; OCCUPATIONAL MEDICINE; OCCUPATIONAL SAFETY; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; WORKMAN COMPENSATION;

EID: 36448953580     PISSN: 10773525     EISSN: None     Source Type: Journal    
DOI: 10.1179/oeh.2007.13.4.404     Document Type: Review

References (206)

1. Tabershaw IR. The health of the enterprise. J Occup Med. 1977;19:523-6.
2. Klem MC, McKiever MF. 50-year chronology of occupational health. J Occup Med. 1966;8:225-34.
3. Farnum CG. Modern industrial medicine. JAMA. 1918;71:336-7.
4. Newquist MN. Occupational medicine. Ind Med. 1946;15:479-80.
5. American Medical Association. Industrial health - postwar [editorial]. JAMA. 1945;128:666-7.
6. American Medical Association. Council on Industrial Health. JAMA. 1948;137:160-1.
7. Kiefer NC. The health of people who work. J Occup Med. 1959;1:545-8.
8. Kehoe RA. Occupational medicine - whither and how! J Occup Med. 1959;1:1-6.
9. Miller SE. Present position of government in occupational health. J Occup Med. 1959;1:27-32.
10. Barnes A. Labor health plans and the industrial physician. J Occup Med. 1959;1:477-8.
11. Sawyer WA. Labor's health goals. J Occup Med. 1959;1:479-82.
12. Nriagu JO. Clair Patterson and Robert Kehoe's paradigm of "show me the data" on environmental lead poisoning. Environ Res. 1998;78:71-8.
13. Anon. A new journal [editorial]. J Occup Med. 1959;1:57-8.
14. Lauer DJ. The President's message. J Occup Med. 1959;1:512.
15. Lauer DJ. The President's message. J Occup Med. 1959;1:614.
16. Occupational Safety and Health Act of 1970, Section 27(a) (1), Pub. L. 91-596, Sec. 27, Dec. 29, 1970, 84 Stat. 1616.
17. Roberts NJ. IMA Reports Nos. 1 and 2. June 1971.
18. McCahan JF. IMA's polition statement on H.R. 14816. J Occup Med. 1968;10:196.
19. Association Activities. Statement of the Industrial Medical Association on H.R. 14816 Occupational Safety and Health Act. J Occup Med. 1968;10:197-8.
20. Committee on Legislation. Current Legislative Notes from the Committee on Legislation. J Occup Med. 1970;12:27a-28a.
21. Egilman DS, Bohme SR. Over a barrel: corporate corruption of science and its effects on workers and the environment. Int J Occup Environ Health. 2005;11:331-7.
22. Huff J. Industry influence on occupational and environmental health. Int J Occup Environ Health. 2007;13:108-17.
23. IMA Report. Report No. 6. October 1971.
24. Ziem GE, Castleman BI. Threshold limit values: historical perspectives and current practice. J Occup Med. 1989;31:910-8.
25. Gerarde H. Letter to Herbert E. Stokinger, Feb. 29, 1956; and Eckardt RE. letter to Herbert E. Stokinger, Feb. 5, 1964, cited in Ziem GE, Castleman BI. The author replies. J Occup Med. 1991;33:947-8.
26. Castleman BI, Ziem GE. Corporate influence on threshold limit values. Am J Ind Med. 1988;13:531-59.
27. Konzen JL. Medical Services Department - Status Report. OCF Intracompany correspondence, March 10, 1969.
28. Report of visit by Dr. John F. Knox to Keasbey & Mattison Company, August 4-5, 1960, Turner & Newall document cited in Castleman BI. Asbestos: Medical and Legal Aspects. 5th ed. New York: Aspen, 2005, p 260.
29. Castleman BI. Asbestos: Medical and Legal Aspects. 5th ed. New York: Aspen, 2005, p 155.
30. IMA Report. Report No. 8. December 1971.
31. Golz HH. EPA's position on the health effects of airborne lead. J Occup Med. 1973;15:369-73.
32. Tabershaw IR. Official health standards. J Occup Med. 1973;15:381.
33. Kahn E, Goldsmith JR. Bias or scientific integrity in governmental standards. J Occup Med. 1973;15:622-3.
34. Kovarik W. Ethyl-leaded gasoline: how a classic occupational disease became an international public health disaster. Int J Occup Environ Health. 2005;11:384-97.
35. Penrose B. Occupational Lead Poisoning in Battery Workers: the Failure to Apply the Precautionary Principle. Labour History. May 2003. .
36. Graebner W. Hegemony through science: information engineering and lead technology, 1925-1965. In, Dying for Work: Worker's Safety and Health in Twentieth Century America. Interdisciplinary Studies in History. Bloomington, IN: Indiana University Press, 1989.
37. Association Activities. Summary of the meeting of the Board of Directors, September 29, 1973. J Occup Med. 1973;15:989-90.
38. Manufacturing Chemists' Association. Occupational Health Committee Meeting, Washington, DC, March 8, 1977, CMA 060361-060367, OHC 183-9.
39. Chemical Manufacturers' Association. Special Projects Expansion and Advocacy (1972-1979). Exhibit I, September 5, 1979, CMA 062498-062526.
40. Nelson KW. The place of biological measurement in standard-setting concepts. J Occup Med. 1973;15:439-40.
41. Smith RG. Occupational exposure to inorganic lead - a critique. J Occup Med. 1973:15:596-8.
42. Halen RJ. The Criteria Document for coke oven emissions. J Occup Med. 1973;15:738-9.
43. Weaver NK. Commentary. J Occup Med. 1974;16:109-11.
44. Eckardt RE. Commentary. J Occup Med. 1976;18:503-4.
45. Eckardt RE. Commentary 2. J Occup Med. 1976;18:572.
46. Utidjian MDU, Tabershaw IR. Commentary. J Occup Med. 1973;15:825-6.
47. Cooper CW. The Criteria Document for Chromic Acid. J Occup Med. 1973;15:986.
48. Key MM. Criteria for a Recommended Standard . . . Occupational Exposure to Coke Oven Emissions. J Occup Med. 1973:15:733.
49. Markowitz G, Rosner D. Deceit and Denial: The Deadly Politics of Industrial Pollution. Berkeley, CA: University of California Press, 2002, pp 226-233. .
50. IMA Report. Report No. 4. August 1971.
51. Hellmuth GA. Medical recommendations and the National Commission on State Workmen's Compensation Laws. Ind Med. 1972;41:20-4.
52. LaDou J. The rise and fall of occupational medicine in the United States. Am J Prev Med. 2002;22:285-95.
53. Association Activities. Summary of the meeting of the Board of Directors, October 3, 1977. J Occup Med. 1978;20:65-6.
54. Eckhardt RE. AOMA position statement on OSHA's generic approach to carcinogen rulemaking. J Occup Med. 1978;20:360-3.
55. AOMA. AOMA criticizes OSHA carcinogen proposal. Occup Health Saf. 1978;47:13.
56. Eckardt RE. The so-called "OSHA Generic Standard on Carcinogens." J Occup Med. 1979;21:566.
57. Infante PF. The past suppression of industry knowledge of the toxicity of benzene to humans and potential bias in future benzene research. Int J Occup Environ Health. 2006;12:268-72.
58. Huff J. Benzene-induced cancers in experimental animals - abridged history and public health benefits of carcinogenesis bioassays. Int J Occup Environ Health. 2007;13:213-20.
59. Kotin P. Standards in the workplace: crisis, crusade or crucible? J Occup Med. 1979;21:557-61.
60. Association Affairs. Summary of the meeting of the Board of Directors. September 18, 1978. J Occup Med. 1979;21:57.
61. Karrh BW. The critical balance: the influence of government regulation, past and present. J Occup Med. 1983;25:21-5.
62. Eisenbud M, Goldwater LJ, Higgins I, et al. AOMA Board expresses concern over quality of NIOSH research. J Occup Med. 1978;20:434-5.
63. McLean AA. Letter endorsing Eisenbud M, Goldwater LJ, Higgins I, et al. AOMA Board expresses concern over quality of NIOSH research. J Occup Med. 1978;20:434-5.
64. Richards B. Schlesinger faults beryllium rule, cites national security. Washington Post. Sept 14, 1978, pp A1, A20.
65. Califano JA, Secretary of HEW letter to Honorable Ray Marshall, Secretary of Labor, informing him that the Surgeon General of the United States will form a review panel to evaluate the NIOSH beryllium studies. September 21, 1978. [with copy to Sec. Schlesinger]
66. Wagoner JK, Infante PF, Bayliss DL. Beryllium: an etiologic agent in the induction of lung cancer, nonneoplastic respiratory disease, and heart disease among industrially exposed workers. Environ Res. 1980;21:15-34.
67. Infante PF, Wagoner JK, Sprince NL. Mortality patterns from lung cancer and nonneoplastic respiratory disease among white males in the beryllium case registry. Environ Res. 1980;21:35-43.
68. Infante P. Internet message to Joe LaDou, April 10, 2007.
69. International Agency for Research on Cancer, World Health Organization. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Beryllium, Cadmium, Mercury and Exposures in the Glass Manufacturing Industry. Lyon, France. IARC Monograph. 1993;58:41-117.
70. Beryllium Industry Scientific Advisory Committee. Is beryllium carcinogenic in humans? J Occup Environ Med. 1997;39:205-8.
71. Vainio H, Rice JM. Beryllium revisited [editorial] J Occup Environ Med. 1997;39:203-4.
72. Occupational Safety and Health Administration, Department of Labor: Semiannual Regulatory Agenda. Occupational exposure to beryllium. Fed Reg. 2000;65:74-120.
73. Infante PF, Newman LS. Beryllium exposure and chronic beryllium disease. Lancet. 2004;363: 415-6.
74. Henshaw JL. Speech delivered at the American Occupational Health Conference, Atlanta, GA, May 7, 2003. .
75. Egilman DS, Bagley S, Biklen M, Golub AS, Bohme SR. The beryllium "double standard" standard. Int J Health Serv. 2003;33:769-812.
76. Infante P. Internet message to Joe LaDou, May 1, 2007.
77. Michaels D, Monforton C. The beryllium occupational exposure limit: historical origin and current inadequacy. J Occup Environ Med. 2006;48:998-1000; author reply 1000-1001.
78. Skrzycki C. OSHA slow to act on beryllium exposure, critic says. Washington Post. February 1, 2005; E01.
79. ACOEM. Government relations. .
80. Guidotti TL. Viewpoint: The invisible specialty: occupational and environmental medicine. AAMC Reporter. April 2007. .
81. Leigh JP, Markowitz SB, Fahs MC, Shin C, Landrigan PJ. Occupational injury and illness in the United States: estimates of costs, morbidity, and mortality. Arch Intern Med. 1997; 157:1557-68.
82. Biddle J, Roberts K, Rosenman KD, Welch EM. What percentage of workers with work-related illnesses receive workers' compensation benefits? J Occup Environ Med. 1998;4: 325-31.
83. Pransky G, Snyder T, Dembe A, et al. Under-reporting of work-related disorder in the workplace: a case study and review of the literature. Ergonomics. 1999;42:171-82.
84. Steenland K, Burnett C, Lalich N, et al. Dying for work: the magnitude of U.S. mortality from selected causes of death associated with occupation. Am J Ind Med. 2003;43:461-82.
85. Strunin L, Boden LI. The workers' compensation system: worker friend or foe? Am J Ind Med. 2004;45:338-45.
86. U.S. Department of Labor. An Interim Report to Congress on Occupational Diseases. Washington, DC: U.S. Department of Labor, 1980.
87. Leigh JP, Robbins JA. Occupational disease and workers' compensation: coverage, costs, and consequences. Milbank Q. 2004;82:689-721.
88. Walsh DC. Corporate Physicians: Between Medicine and Management. New Haven, CT: Yale University Press, 1987.
89. LaDou J. Occupational medicine: the case for reform. Am J Prev Med. 2005;28:396-402.
90. Harris JS, Glass LS, Mueller KL, Genovese E. ACOEM Practice Guidelines Committee. Evidence-based clinical occupational medicine: updating the ACOEM occupational medicine practice guidelines [review]. Clin Occup Environ Med. 2004;4:viii, 341-60.
91. ACOEM Occupational Medicine Practice Guidelines. 2nd ed. 2007. .
92. Barbanel C, Guidotti TL, Auerbach K. Occupation medicine the case for reform. Am J Prev Med. 2006;30:186.
93. Nuckols TK, Winn BO, Lim Y-W, et al. Evaluating medical treatment guideline sets for injured workers in California. Rand, .
94. American Society of Mechanical Engineers, Inc. v. Hydrolevel Corp., 456 U.S. 556 (1982).
95. Radiant Burners, Inc. v. Peoples Gas Light & Coke Co., 364 U.S. 656 (1961).
96. Ward EM, Schulte PA, Bayard S, et al. Priorities for development of research methods in occupational cancer [review]. Environ Health Perspect. 2003;111:1-112.
97. LaDou J. Occupational and environmental medicine in the United States: a proposal to abolish workers' compensation and reestablish the public health model. Int J Occup Environ Health. 2006;12:154-68.
98. Huff J. Occupational cancer: an international disgrace. Int J Occup Environ Health. 2008;14: in press..
99. LaDou J. The asbestos cancer epidemic. Environ Health Perspect. 2004;112:285-90.
100. Tomatis L. Identification of carcinogenic agents and primary prevention of cancer. Ann NY Acad Sei. 2006;1076:1-14.
101. Tomatis L, Huff J. Evolution of cancer etiology and primary prevention. Environ Health Perspect. 2001;109:A458-460.
102. Tomatis L, Melnick RL, Haseman J, Barrett JC, Huff J. Alleged misconceptions distort perceptions of environmental cancer risks. FASEB J. 2001;15:195-203.
103. Tomatis L, Huff J, Hertz-Picciotto I, et al. Avoided and avoidable risks of cancer. Carcinogenesis. 1997;18:97-105.
104. CEO Cancer Gold Standard. .
105. Barab J. ACOEM: Embarrassing themselves yet again. Confined Space. News and Commentary on Workplace Health & Safety, Labor and Politics Saturday, September 2, 2006. .
106. Higgins P, Orris P. Providing employer-arranged occupational medical care: conflicting interests. Occup Med. 2002;17:601-6.
107. Morton WE. The rise and fall of occupational medicine in the United States [letter]. AmJ Prev Med. 2002;23:309.
108. Lax MB, Manetti FA, Klein RA. Medical evaluation of work related illness: a comparison of evaluations by a treating occupational medicine specialist and independent medical examiners. Int J Occup Environ Health. 2004;10:1-12.
109. Sass JB. Industry efforts to weaken EPA health assessment of 1,3-butadiene. Int J Occup Environ Health. 2005;11:378-83.
110. Bohme SR, Zorabedian J, Egilman DS. Maximizing profit and endangering health: corporate strategies to avoid litigation and regulation. Int J Occup Environ Health. 2005;11:338-48.
111. Breilh J, Branco Jefer C, et al. Texaco and its consultants. Int J Occup Environ Health. 2005;11:217-20.
112. Kassirer JP, Cecil JS. Inconsistency in evidentiary standards for medical testimony: disorder in the courts. JAMA. 2002;288:1382-7.
113. Brodkin CA, Frumkin H, Kirkland KH, et al. Choosing a professional code for ethical conduct in occupational and environmental medicine. J Occup Environ Med. 1998;40:840-2.
114. ACOEM. Code of ethical conduct, .
115. Goodman KW. Codes of ethics in occupational and environmental health [editorial]. J Occup Environ Med. 1996;38:882-3.
116. Brodkin CA, Frumkin H, Kirkland KH, Orris P, Schenk M. AOEC position paper on the organizational code for ethical conduct. J Occup Environ Med. 1996;38:869-81.
117. Teichman RF. ACOEM Code of Ethical Conduct. American College of Occupational and Environmental Medicine. J Occup Environ Med. 1997;39:614-5.
118. Rothstein MA. A proposed revision of the ACOEM Code of Ethics. American College of Occupational and Environmental Medicine. J Occup Environ Med. 1997;39:616-22.
119. LaDou J, Tennenhouse DJ, Feitshans IL. Codes of ethics (conduct) [review]. Occup Med. 2002;17:559-85.
120. ACOEM. Guidelines for protecting health care workers against tuberculosis. JOccup Environ Med. 1998;40:765-7.
121. Ducatman AM, McLellan RK. Epidemiologic basis for an occupational and environmental policy on environmental tobacco smoke. J Occup Environ Med. 2000;42:1137-41.
122. Committee Report. ACOEM reproductive hazard management guidelines. J Occup Environ Med. 1996;38:83-90.
123. Sass JB, Castleman B, Wallinga D. Vinyl chloride: a case study of data suppression and misrepresentation. Environ Health Perspect. 2005;113:809-12.
124. Egilman D, Scout. Corporate corruption of science - the case of chromium (VI). Int J Occup Environ Health. 2006;12:169-76.
125. Friedman L, Richter ED. Conflicts of interest and scientific integrity. Int J Occup Environ Health. 2005;11:205-6.
126. Egilman D, Scout, Kol L, Hegg LA, Bohme SR. Manipulated data in Shell's benzene historical exposure study. Int J Occup Environ Health. 2007;13:222-32.
127. Burns CJ, Carson ML, Cartmill JB. Cause-specific mortality among employees of a Texas-based chemical manufacturing facility, 1940-1996. Texas Med. 2003; 99:67-73.
128. Burns CJ, Kociba R. Dow Chemical scientists respond to allegations of suppression of research results. J Occup Environ Health. 2003;45:914-5.
129. Egilman DS. Suppression bias at the Journal of Occupational and Environmental Medicine. Int J Occup Environ Health. 2005;11:202-4.
130. Sass J. U.S. Department of Defense and White House working together to avoid cleanup and liability for Perchlorate pollution. Int J Occup Environ Health. 2004;10:330-4.
131. Kelsh MA, Buffler PA, Daaboul JJ, et al. Primary congenital hypothyroidism, newborn thyroid function, and environmental Perchlorate exposure among residents of a Southern California community. J Occup Environ Med. 2003;45:1116-27.
132. Axelson O, Balbus JM, Cohen G, et al. Re: Regulatory Toxicology and Pharmacology. Int J Occup Environ Health. 2003;9:386-9.
133. Jacobson MF, Sharpe VA, Angell M, et al. Editorial policies on financial disclosure. Nat Neurosci. 2003;6:1001.
134. Sharpe VA, Gurian-Sherman D. Competing interests. Nat Biotechnol. 2003;21:1131.
135. Jacobson MF. Lifting the veil of secrecy from industry funding of nonprofit health organizations. Int J Occup Environ Health. 2005;11:349-55.
136. Bailar JC 3rd, Ballal SG, Boback M, et al. FIOH-sponsored newsletter misrepresents asbestos hazards in Zimbabwe. Int J Occup Environ Health. 2006;12:254-8.
137. Axelson O, Castleman B, Epstein S, et al. Re: Implementation of WHO Guidelines on Disclosure of Interest by members of WHO expert panels. Int J Occup Environ Health. 2002;8:271-3.
138. Castleman BI. Controversies at international organizations over asbestos industry influence. Int J Health Serv. 2001;31:193-202.
139. Melnick RL. Suppression of crucial information in the IARC evaluation of DEHP. Int J Occup Environ Health. 2003;9:84-5.
140. Melnick RL, Brody C, DiGangi J, Huff J.The IARC evaluation of DEHP excludes key papers demonstrating carcinogenic effects. Int J Occup Environ Health. 2003;9:400-2.
141. Huff J. Industry influences IARC carcinogenesis evaluations. IntJ Occup Environ Health. 2003;9:83-4.
142. Huff J. IARC and the DEHP quagmire. Int J Occup Environ Health. 2003;9:402-4.
143. Huff J. IARC monographs, industry influence, and upgrading, downgrading, and under-grading chemicals: a personal point of view. International Agency for Research on Cancer. Int J Occup Environ Health. 2002;8:249-70.
144. Needleman H, Huff J. The International Agency for Research on Cancer and obligate transparency. Lancet Oncol. 2005;6:920-1.
145. Zhang JD, Li S. Cancer mortality in a Chinese population exposed to hexavalent chromium in water. J Occup Environ Med. 1997;39:315-319. Retraction in: Brandt-Rauf P. J Occup Environ Med. 2006;48:749.
146. Waldman P. Publication to retract an influential water study. Wall Street Journal. May 2, 2006, p 10.
147. Clapp R, Hoppin P, Kriebel D. Erosion of the integrity of public health science in the USA. Occup Environ Med. 2006;63;367-8.
148. California Department of Health Services [homepage on the internet]. Scientific Review of Toxicological and Human Health Issues Related to the Development of a Public Health Goal for Chromium (VI) [updated 8-30-2001; cited 12-29-2005],
149. Flegal R, Last J, McConnell EE, Schenker M, Witschi H .
150. National Toxicology Program. Toxicology and carcinogenesis studies of sodium dichromate dihydrate (CAS No. 7789-12-0) in F344/N rats and B6C3F1 mice (Drinking Water Studies). June 2007. .
151. Dweck A, Lurie P, Michaels D, Wolfe S. Hexavalent chromium study's conclusions unjustified. J Occup Environ Med. 2005; 47:980-1; author reply 981.
152. Sass J, Janssen S. Process and content concerns in BPA review. The Pump Handle, March 9, 2007.
153. Rust S. Bisphenol-A is in products from bottles to dental sealants. The Milwaukee Journal Sentinel. March 8, 2007. .
154. Rosenstock L, Lee LJ. Attacks on science: the risks to evidence-based policy. Am J Public Health. 2002;92:14-8.
155. Cranor CF. Science with health consequences. Int J Occup Environ Health. 2006;12:177-9.
156. Sass J. Credibility of scientists: conflict of interest and bias. Environ Health Perspect. 2006;114:147-8.
157. Michaels D. Manufactured uncertainty: protecting public health in the age of contested science and product defense. Ann NY Acad Sci. 2006;1076:149-162.
158. Bailar JC III. How to distort the scientific record without actually lying: truth, and the arts of science. Eur J Oncol. 2006;11:217-24.
159. LaDou J, Bailar JD III. Cancer and reproductive risks in the semiconductor industry. Int J Occup Environ Health. 2007;13:376-85.
160. Parodi S, Gennaro V, Ceppi M, Cocco P. Comparison bias and dilution effect in occupational cohort studies. Int J Occup Environ Health. 2007;13:143-52.
161. Hansen JA. OSHA regulation of ergonomie health. J Occup Med. 1993;35:42-6.
162. Keyserling WM, Chaffin DB. Occupational ergonomics-methods to evaluate physical stress on the job. Annu Rev Public Health. 1986;7:77-104.
163. ACOEM. Statement in opposition to the Ergonomie Standard, November 16, 2000, 06:53:44-0500. .
164. Hadler NM. Comments on the "Ergonomics Program Standard" proposed by the Occupational Safety and Health Administration. J Occup Environ Med. 2000;42:951-69.
165. Punnett L. Commentary on the scientific basis of the proposed Occupational Safety and Health Administration Ergonomics Program Standard. J Occup Environ Med. 2000;42:970-81.
166. Chaffin DB. Improving digital human modelling for proactive ergonomics in design. Ergonomics. 2005;48:478-91.
167. Biddle J, Roberts K. More evidence of the need for an ergonomic standard. Am J Ind Med. 2004;45:329-37.
168. Spieler EA, Burton FJ Jr. Compensation for disabled workers: workers' compensation. In: Thomason TF, Burton JF Jr, Hyatt DE (eds). New Approaches to Disability in the Work Place. Madison, WI: Industrial Relations Research Association, 1999.
169. Morse TF, Dillon C, Warren N, et al. Capture-recapture estimation of unreported work-related musculoskeletal disorders in Connecticut. Am J Ind Med. 2001;39:636-42.
170. Wellman H, Davis L, Punnett L, et al. Work-related carpal tunnel syndrome (WR-CTS) in Massachusetts, 1992-1997: source of WR-CTS, outcomes, and employer intervention practices. Am J Ind Med. 2004;45:139-52.
171. Peterson KW. Employee drug screening: issues to be resolved in implementing a program. Clin Chem. 33;54B-60B.
172. ACOEM Policy Statement. Ethical Aspects of Drug Testing. February 14, 2006. .
173. Lippin RA. The Company Doctor-Risk, Responsibility and Professionalism [book review]. J Occup Environ Med. 2005;47:535-6.
174. Draper E. The Company Doctor: Risk, Responsibility, and Corporate Professionalism. New York: Russell Sage Foundation, 2003.
175. AOHC. American Occupational Health Conference (AOHC® 2007). Component and Section Meetings. .
176. AOEC. What is AOEC? .
177. OMB Watch. 2006. Assistance to Association of Occupational & Environment in DC (FY 2000-2006). .
178. AOEC News. .
179. Ashford NA, Castleman B, Frank AL, et al. International Commission on Occupational Health (ICOH) and its influence on international organizations. Int J Occup Envoiron Health. 2002;8:156-62.
180. LaDou J. ICOH caught in the act. Arch Environ Health. 1998;53:247-8.
181. Richter ED, Berman T. Seattle and the ICOH: the view from the other side of the globe [editorial]. Int J Occup Environ Health. 2000;6:161-3.
182. Watterson A. ICOH and the pesticide industry [editorial]. Int J Occup Environ Health. 2000;6:73-6.
183. Castleman BI. Controversies at international organizations over asbestos industry influence. Int J Health Serv. 2001;31:193-202.
184. ICOH. Centennial meeting. ICOH - Events, . 28th International Congress on Occupational Health, 2006. .
185. Hardin BD, Kelman BJ, Saxon A. Adverse human health effects associated with molds in the indoor environment [review]. J Occup Environ Med. 2003;45:470-8.
186. Kilburn KH, Gray M, Kramer S. Nondisclosure of conflicts of interest is perilous to the advancement of science. J Allerg Clin Immunol. 2006:118:766-7.
187. Institute of Medicine. Damp Indoor Spaces and Health. Released on May 25, 2004. .
188. Armstrong D. Court of opinion amid suits over mold, experts wear two hats. Authors of science paper often cited by defense also help in litigation. Wall Street Journal. January 9, 2007; A1.
189. Guidotti TL, McLellan RK, Borak J. Adverse human health effects associated with molds in the indoor environment. Ambush above the fold: ACOEM response to recent mold issue, .
190. Robbins CA, Swenson LJ, Nealley ML, Gots RE, Kelman BJ. Health effects of mycotoxins in indoor air: a critical review. Appl Occup Environ Hyg. 2000;15:773-84.
191. Borak J. Internet message to Dean Grove, Past President of ACOEM, Edward Bernacki, President of ACOEM, Timothy Key, ACOEM President Elect, and Barry Eisenberg, Executive Director, ACOEM, September 8, 2002.
192. U.S. Chamber of Commerce. Center for Legal Policy. A Scientific View of the Health Effects of Mold. Bryan Hardin, PhD (Veritox), Andrew Saxon MD (UC), Correen Robbins, PhD, CIH (Veritox) and Bruce J. Kelman, PhD, DABT (Veritox). .
193. Haynes vs. Adair Homes, Jury finds "toxic mold" harmed Oregon family, builder's arbitration clause not binding, March 9, 2005. .
194. Harolds vs. California Casualty. James Harold and D. Lee Harold, Plaintiffs vs. California Casualty Insurance Company and Westmont Construction, Inc., Defendants, Case # 02AS04291, April 13, 2006.
195. FDA News. Toxic mold causes memory loss, judgment effects. For immediate release, April 1, 2007. .
196. Kirkland KH, Greenberg G. Internet message of apology sent to Sharon Kramer, April 2, 2007.
197. OSHA. Preventing Mold-Related Problems in the Indoor Workplace. A Guide for Building Owners, Managers and Occupants. Department of Labor. OSHA 334-04N 2006. .
198. NIOSH. Occupational Respiratory Disease Surveillance. Other related resources, .
199. EPA. Mold Remediation in Schools and Commercial Buildings. Resources list, .
200. Robbins CA, Swenson LJ, Hardin BD [principals of the litigation defense support corporation, Veritox, Inc., formerly named GlobalTox, Inc.], Risk from inhaled mycotoxins in indoor office and residential environments. Int J Toxicol. 2004;23:3-10.
201. Christian JH, Leopold R, Mueller KL, et al. ACOEM's eight best ideas for workers' compensation reform. Committee Report. J Occup Environ Med. 1998;40:207-9.
202. Committee Report. Occupational and environmental medicine competencies. J Occup Environ Med. 1998;40:427-40.
203. LaDou J. The occupational medicine consultant. Am J Ind Med. 1991;19:257.
204. Walsh DC. Corporate Physicians: Between Medicine and Management. New Haven, CT: Yale University Press, 1987.
205. Guidotti TL. Internet message to Rick Lippin, December 2, 2006.
206. Guidotti TL. From Your President: Last Thoughts. Internet message to ACOEM members, April 25, 2007.